What one share of Greenland Mines holds
On September 12, 2022, the Company acquired five market-approved anti-cancer drugs approved for sale in Germany. The Market Authorizations (MA’s) are for four of the drugs that comprise the “FOLFOX”
Greenland Mines’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.25 |
|---|---|
| Cash and investments | $0.06 |
| Book value | $0.36 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | — | −$0.05 | — | — | $16.50 | −$0.03 |
| 2024 | — | −$0.32 | — | — | — | $0.04 |
| 2025 | — | −$0.22 | — | — | — | $0.13 |
Common questions about Greenland Mines
How much does one share of Greenland Mines earn?
Over the last 12 months, Greenland Mines lost $0.25 for each share.
Does Greenland Mines pay a dividend?
Greenland Mines didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Greenland Mines’s book value per share?
Greenland Mines’s book value is $0.36 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Greenland Mines have?
Each share of Greenland Mines has $0.06 of cash and investments, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.